Date published: 2026-7-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rab GDI α CRISPR/Cas9 KO Plasmid (h): sc-404659

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • Rab GDI α CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Rab GDI α genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Rab GDI α Antibody (C-7): sc-271846
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    Rab GDI α CRISPR/Cas9 KO Plasmid (h)

    sc-404659
    20 µg
    $397.00

    Overview

    GDI1 encodes Rab GDP dissociation inhibitor alpha (Rab GDI α), a cytosolic chaperone that binds prenylated Rab GTPases and regulates their extraction from membranes, solubilization, and recycling between donor and acceptor compartments. By controlling Rab availability and localization, Rab GDI α helps coordinate vesicle budding, trafficking, and fusion across endocytic and secretory pathways, supporting organelle identity and cargo sorting. Disruption of GDI1 perturbs Rab-dependent trafficking networks that are critical for synaptic vesicle cycling and neuronal homeostasis, linking altered membrane transport to neurodevelopmental and neurological disease phenotypes. As a central node in small GTPase regulation, GDI1 is frequently studied in the context of endosome dynamics, Golgi-to-plasma membrane transport, and synaptic function.

    Rab GDI α CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GDI1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GDI1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.

    The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GDI1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Rab GDI α protein expression.

    This CRISPR knockout system enables efficient generation of GDI1-deficient cell models for investigation of Rab GDI α signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.

    Key Features

    • sgRNAs targeting GDI1 exon(s) critical for Rab GDI α function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • GFP reporter for identification of transfected cells
    • Pool of plasmids targeting multiple GDI1 genomic sites to improve knockout efficiency
    • Compatible with delivery by transfection

    Design Variants

    CRISPRs +/- HDRs

    • gRNAs encoded by Rab GDI α CRISPR/Cas9 KO Plasmid (h) and Rab GDI α CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the GDI1 locus. One or both targeting designs may be available. See Related Products for availability.
    • HDR donor constructs encoded by Rab GDI α HDR Plasmid (h) and Rab GDI α HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by GDI1 homology arms to support homology-directed repair at defined GDI1 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.